Testing effectiveness (Phase 2)Ended earlyNCT02603146
What this trial is testing
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Who this might be right for
Healthy ParticipantsRheumatoid Arthritis (RA) Prevention
National Institute of Allergy and Infectious Diseases (NIAID) 144